| Date | Product | Disease | Phase | Company | Therapeutic area |
|---|---|---|---|---|---|
| 2015-07-22 | PF-06751979 | Alzheimer\'s disease | 1 | Pfizer (USA - NY) | Neurodegenerative diseases |
| 2015-07-22 | RVT-101 | Alzheimer's disease | 2b | Axovant Sciences (Bermuda - USA - NY) | Neurodegenerative diseases |
| 2015-07-22 | AVI-7288 | Marburg Virus (MARV) infection | 1 | Sarepta Therapeutics (USA - MA) | Infectious diseases |
| 2015-07-22 | gevokizumab ( XOMA 052/S 78989) | Behçet's uveitis |
3 | Xoma (USA - CA) Laboratoires Servier (France) | Ophtalmological diseases - Rare diseases |
| 2015-07-22 | AZD9412 (inhaled interferon beta formerly known as SNG001) | severe asthma | 2a | AstraZeneca (UK) | Allergic diseases - Inflammatory diseases - Respiratory diseases |
| 2015-07-22 | Amyvid® (florbetapir 18F) | knowledge of amyloid status | Eli Lilly (USA - IN) | Neurodegenerative diseases | |
| 2015-07-21 | MN-001 (tipelukast) | idiopathic pulmonary fibrosis | 2 | Medicinova (USA - CA) | Rare diseases - Lung diseases - Respiratory diseases |
| 2015-07-21 | SYN115 (tozadenant) | Parkinson's disease | 3 | Biotie Therapies (Finland) | Neurodegenerative diseases - CNS diseases |
| 2015-07-21 | ISIS-HTTRx | Huntington\'s disease |
1-2a | Isis Pharmaceuticals (USA - CA) Roche (Switzerland) | Genetic diseases - Neurodegenerative diseases - Rare diseases |
| 2015-07-21 | masitinib | non-resectable or metastatic stage 3 or stage 4 melanoma carrying a mutation in the juxtamembrane domain of c-Kit | 3 | AB Science (France) | Cancer - Oncology |
| 2015-07-21 | buparlisib (BKM120) | breast cancer | 3 | Novartis (Switzerland) | Cancer - Oncology |
| 2015-07-21 | single tablet regimen containing elvitegravir 150 mg, cobicistat 150 mg, emtricitabine 200 mg and tenofovir alafenamide (TAF) 10 mg (E/C/F/TAF) | HIV-1 infection | 3 | Gilead (USA - CA) | Infectious diseases |
| 2015-07-20 | omigapil | congenital muscular dystrophy | 1 | Santhera Pharmaceuticals (Switzerland) | Neuromuscular diseases - Rare diseases - Genetic diseases |
| 2015-07-20 | Multikine® (Leukocyte Interleukin, Injection) | Human Papilloma Virus associated peri-ana wart immunotherapy in HIV/HPV co-infected men and women | 1-2 | Cell-Sci Corporation (USA - VA) | Infectious diseases |
| 2015-07-19 | VAC-3S immunotherapy | HIV/AIDS | 1-2a | Innavirvax (France) | Infectious diseases |
| 2015-07-18 | THV01 - anti-HIV therapeutic vaccine candidate based on lentiviral vector technology | HIV/Aids |
1-2 | Theravectys (France) | Infectious diseases |
| 2015-07-17 | C2N-8E12 - recombinant humanized anti-tau antibody | progressive supranuclear palsy |
1 | C2N Diagnostics (USA - MO) AbbVie (USA - IL) | Rare diseases - Neurodegenerative diseases - Neurological diseases |
| 2015-07-16 | VIS513 | dengue fever |
preclinical | Visterra (USA - MA) | Infectious diseases |
| 2015-07-16 | Blincyto® (blinatumomab) | relapsed or refractory Philadelphia chromosome-positive (Ph+) B-cell precursor acute lymphoblastic leukemia (ALL) | 2 | Amgen (USA - CA) | Cancer - Oncology - Rare diseases |
| 2015-07-16 | TALEN®-mediated genome editing | Cellectis (France) |
